Search

everythinglearnresearchcommunity

for

Search:↓

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Some nonsurgical hair loss treatments are effective, especially if started early.

A Japanese patient with IFAP syndrome had a severe MBTPS2 gene mutation but showed milder symptoms than previously observed cases.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Alternative treatments show promise for hair growth beyond traditional methods.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Finasteride use may increase the risk of male breast cancer.

Androgens can both increase body hair and cause scalp hair loss.